Working Paper
Carpenter D, Armstrong E, Hojnacki M. The Effect of Published Medical Research upon Media Attention to Disease, Twenty-Year Sample . Working Paper.
Carpenter D, Tobbell D. “Bioequivalence: The Regulatory Career of a Pharmaceutical Concept” . Bulletin of the History of Medicine. Submitted.
Carpenter D, Krause G. Reputation and Public Administration. Public Administration Review. Forthcoming;72 (1) :26 - 32.
Carpenter D, Schneer B. Party Formation through Petitions: The Whigs and the Bank War of 1832 - 1834. Studies in American Political Development. 2015;29 (2) :213 - 234.
Einhorn R, Schickler E, Anthony S. C. Studies in American Political Development. 2014.
Thomas J. S, Carpenter D, Aaron S. K. Target small firms for antibiotic innovation. Science. 2014;344 (6187) :967 - 969.
Carpenter D, Moore CD. When Canvassers Became Activists: Antislavery Petitioning and the Political Mobilization of American Women. American Political Science Review. 2014;108 (3) :479 - 498.
Carpenter D. La pétition antiesclavagiste américaine au 19eme siècle -- Leçons et possibilités de recherches comparatives, in Pétitionner. ; 2013.
Carpenter D, David A. M. Preventing Regulatory Capture. Cambridge University Press; 2013.
Carpenter D, Chattopadhyay J, Moffitt S, Nall C. The Complications of Controlling Agency Time Discretion: FDA Deadlines and Postmarket Drug Safety. American Journal of Political Science. 2012.
Reputation and Power: Organizational Image and Pharmaceutical Regulation at the FDA
Carpenter D. Reputation and Power: Organizational Image and Pharmaceutical Regulation at the FDA.; 2010. Publisher's Version i9205.pdf
Carpenter D, Keyhani S, Anderson G, Hebert P, Wang S. “U.S. Pharmaceutical Innovation in an International Context” . American Journal of Public Health [Internet]. 2010;(6) :1075-1080. Publisher's Version
Carpenter D, Grimmer J, Lomazoff E. “Approval Regulation and Endogenous Consumer Confidence: Theory and an Analogies to Licensing, Safety and Financial Regulation”. Regulation and Governance . 2010;4 (4).
Carpenter D, Moffitt S, Moore C, Rynbrandt R, Ting M, Yohai I, Zucker EJ. Early-Entrant Protection in Approval Regulation: Theory and Evidence from FDA Drug Review. Journal of Law Economics and Organization . 2010;26 (2).
Carpenter D. “Institutional Strangulation: Bureaucratic Politics and Financial Reform in the Obama Administration”. Perspective on Politics. 2010;8 (3) :825-46.
Carpenter D. “Reputation Information and Confidence – The Political Economy of Pharmaceutical Regulation”. Public Choice and Public Law . 2010.
Carpenter D, Grimmer J. The Trouble with Deadlines. 2009. downside.pdf
Carpenter D, Balleisen E, Moss D. “Confidence Games: How Does Regulation Constitute Markets?”. In: Towards a New Theory of Regulation. New York : Cambridge University Press ; 2009.
Carpenter D, Kazin M. “Regulation”. In: The Princeton Encyclopedia of Political History . ; 2009.